Predictors of Hospital Readmission for Chronic Obstructive Pulmonary Disease Patients

April 4, 2024 updated by: Rougina Girgis Kamel Boles, Assiut University

Predictors of Hospital Readmission for Chronic Obstructive Pulmonary Disease Patients,A Prospective Cohort Study

This study is aimed to determine the risk factors for hospital readmission within 6 months in COPD patients

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

This study is aimed to determine the risk factors for hospital readmission within 6 months in COPD patients and develop early warning model

Study Type

Observational

Enrollment (Estimated)

188

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

this study is a prospective hospital-based cohort study

Description

Inclusion Criteria:

  • All COPD patients of both genders diagnosed by (GOLD) Guidelines (2024 Revision).
  • Cooprative patients who accept to participate in the current study .

Exclusion Criteria:

  • patients with cognitive impairment ,and unable to answer needed questions.
  • patients with other lung diseases such as active pulmonary tuberculosis ,asthma ,bronchiactesis,and pulmonary embolism .
  • patients with incomplete clinical data .
  • Refused to participate in the current study .

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
assessment of potential predictors of readmission among COPD patients
Time Frame: 6 months
using CCI (charlson comorbidity index)
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
development of early warning model for hospital readmission in COPD patients
Time Frame: within 6 months
using CCI (charlson comorbidity index)
within 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Assiut University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2024

Primary Completion (Estimated)

May 1, 2026

Study Completion (Estimated)

June 1, 2026

Study Registration Dates

First Submitted

March 25, 2024

First Submitted That Met QC Criteria

April 4, 2024

First Posted (Actual)

April 5, 2024

Study Record Updates

Last Update Posted (Actual)

April 5, 2024

Last Update Submitted That Met QC Criteria

April 4, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • predictors of readmission

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hospital Radmission for COPD Patients

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe